BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Aug 27, 2026; 18(8): 117559
Published online Aug 27, 2026. doi: 10.4240/wjgs.117559
Table 6 Univariate analysis of factors affecting overall survival
Factor
HR
95%CI
P value
Gender (male vs female)1.2680.698-2.3040.436
Age (> 60 years vs ≤ 60 years)1.3950.774-2.5160.268
ECOG score (2 vs 0-1)1.6840.782-3.6260.182
Tumor location (colon vs rectum)0.8560.465-1.5760.619
Differentiation (poor vs moderate-well)1.5380.762-3.1040.229
pT stage (T4 vs T3)a1.9821.096-3.5840.023a
pN stage (N2 vs N0-1)a2.1561.268-3.6660.004a
Lymph node metastasis (N+ vs N0)a2.0341.205-3.4340.008a
Vascular invasion (yes vs no)a1.6580.928-2.9640.089a
Neural invasion (yes vs no)a1.8121.022-3.2130.042a
Margin status (positive vs negative)a2.4861.352-4.5720.003a
Preoperative CEA (elevated vs normal)a1.7461.036-2.9440.036a
Preoperative CA19-9 (elevated vs normal)1.4620.802-2.6650.214
Surgical approach (laparoscopic vs open)0.7950.444-1.4240.442
Neoadjuvant therapy (yes vs no)0.7280.362-1.4650.374
Chemotherapy regimen (single vs combination)1.3180.725-2.3970.364
Target delineation (inaccurate vs accurate)a2.5421.426-4.5320.001a


Write to the Help Desk